Month: March 2025

What are the latest developments at the FDA in risk-based quality management of GCP audits? The U.S. Food and Drug Administration (FDA) has been continuously advancing its approach to Good Clinical Practice (GCP) audits by emphasizing risk-based quality management.  This strategy focuses on identifying and managing potential risks to patient safety and data integrity throughout…
Learn More ▸